Colin G. De Haar
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit.
Journal: Immuno-oncology technology
Published: January 09, 2024
Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study.
Journal: The Lancet. Neurology
Published: November 22, 2021
Clinical Grade Production of Wilms' Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation.
Journal: Frontiers in immunology
Published: May 05, 2020
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.
Journal: Bone marrow transplantation
Published: January 20, 2020
Adipocytes harbor a glucosylceramide biosynthesis pathway involved in iNKT cell activation.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: February 23, 2018
Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters.
Journal: Clinical and experimental gastroenterology
Published: May 13, 2017
Analysis of SHIP1 expression and activity in Crohn's disease patients.
Journal: PloS one
Published: February 20, 2017
Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.
Journal: Journal of virology
Published: November 08, 2014
Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.
Journal: Oncoimmunology
Published: October 08, 2014
Last Updated: 09/26/2026